1. Home
  2. DBVT vs UONEK Comparison

DBVT vs UONEK Comparison

Compare DBVT & UONEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBVT
  • UONEK
  • Stock Information
  • Founded
  • DBVT 2002
  • UONEK 1980
  • Country
  • DBVT France
  • UONEK United States
  • Employees
  • DBVT N/A
  • UONEK N/A
  • Industry
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • UONEK Broadcasting
  • Sector
  • DBVT Health Care
  • UONEK Consumer Discretionary
  • Exchange
  • DBVT Nasdaq
  • UONEK Nasdaq
  • Market Cap
  • DBVT 67.8M
  • UONEK 63.4M
  • IPO Year
  • DBVT N/A
  • UONEK N/A
  • Fundamental
  • Price
  • DBVT $3.12
  • UONEK $1.00
  • Analyst Decision
  • DBVT Strong Buy
  • UONEK
  • Analyst Count
  • DBVT 2
  • UONEK 0
  • Target Price
  • DBVT $22.50
  • UONEK N/A
  • AVG Volume (30 Days)
  • DBVT 363.4K
  • UONEK 28.2K
  • Earning Date
  • DBVT 11-06-2024
  • UONEK 11-12-2024
  • Dividend Yield
  • DBVT N/A
  • UONEK N/A
  • EPS Growth
  • DBVT N/A
  • UONEK N/A
  • EPS
  • DBVT N/A
  • UONEK N/A
  • Revenue
  • DBVT $12,515,000.00
  • UONEK $452,891,000.00
  • Revenue This Year
  • DBVT N/A
  • UONEK N/A
  • Revenue Next Year
  • DBVT $2,860.00
  • UONEK N/A
  • P/E Ratio
  • DBVT N/A
  • UONEK N/A
  • Revenue Growth
  • DBVT 125.54
  • UONEK N/A
  • 52 Week Low
  • DBVT $0.44
  • UONEK $0.92
  • 52 Week High
  • DBVT $4.50
  • UONEK $4.12
  • Technical
  • Relative Strength Index (RSI)
  • DBVT 60.52
  • UONEK 44.50
  • Support Level
  • DBVT $3.02
  • UONEK $0.99
  • Resistance Level
  • DBVT $3.93
  • UONEK $1.04
  • Average True Range (ATR)
  • DBVT 0.31
  • UONEK 0.08
  • MACD
  • DBVT -0.06
  • UONEK -0.00
  • Stochastic Oscillator
  • DBVT 6.76
  • UONEK 13.09

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Viaskin targets specific antigen-presenting immune cells in the skin, called Langerhans cells, that capture the antigen and migrate to the lymph node to activate the immune system without passage of the antigen into the bloodstream, minimizing systemic exposure in the body. Its main product candidate is Viaskin Peanut for the treatment of peanut-allergic patients.

About UONEK Urban One Inc. Class D

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

Share on Social Networks: